$glp-1 heart failure reduced ejection fraction Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in GLP-1 receptor agonists, including semaglutide$

glp-1 heart failure reduced ejection fraction

glp-1 heart failure reduced ejection fraction Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in GLP-1 receptor agonists, including semaglutide

Name: glp-1 heart failure reduced ejection fraction Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in GLP-1 receptor agonists, including semaglutide
Brand: 2m-capital.com
SKU: 61586646079
Price: 26.62 USD
Availability: InStock
Rating: 4.5859000000000005 (24 reviews)

SKU: 61586646079

4.6

EUR26.62 EUR66.62

Pay in 4 interest-free payments of $6.66 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 9 - Nov 14

Description

BMJ (Online) 355

$glp-1 heart failure reduced ejection fraction Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 SodiumGlucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in GLP-1 receptor agonists, including semaglutide$